Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test

Overview

Journal Crit Care Med

Specialties Critical Care
Emergency Medicine

Date 2016 Mar 11

PMID 26963329

Citations 14

Authors

Kitty S Chan

Lisa Aronson Friedman

Victor D Dinglas

Catherine L Hough

Peter E Morris

Pedro A Mendez-Tellez

James C Jackson

E Wesley Ely

Ramona O Hopkins

Dale M Needham

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the reliability, validity, responsiveness, and minimal important difference of the 4-m gait speed test in acute respiratory distress syndrome survivors.

Design: Secondary analyses of data from two longitudinal follow-up studies of acute respiratory distress syndrome survivors. Test-retest and inter-rater reliability, construct validity (convergent, discriminant, and known group), predictive validity, and responsiveness were examined. The minimal important difference was estimated using anchor- and distribution-based approaches.

Setting: A national multicenter prospective study (ARDSNet Long-Term Outcome Study) and a multisite prospective study in Baltimore, MD (Improving Care of Acute Lung Injury Patients).

Patients: Acute respiratory distress syndrome survivors with 4-m gait speed assessment up to 60 months after acute respiratory distress syndrome (ARDSNet Long-Term Outcome Study, n = 184; Improving Care of Acute Lung Injury Patients, n = 122).

Interventions: Not applicable.

Measurements And Main Results: Four-meter gait speed was assessed at 6- and 12-month follow-up (ARDSNet Long-Term Outcome Study) and 36-, 48-, and 60-month follow-up (Improving Care of Acute Lung Injury Patients). Excellent test-retest (intraclass correlation, 0.89-0.99 across studies and follow-up) and inter-rater (intraclass correlation, 0.97) reliability were found. Convergent validity was supported by moderate-to-strong correlations (69% of 32 > 0.40) with other physical function measures. Discriminant validity was supported by weak correlations (86% of 28 < 0.30) with mental health measures. Survivors with impaired versus nonimpaired measures of muscle strength and pulmonary function had significantly slower 4-m gait speed (all but one p < 0.05). Furthermore, 4-m gait speed significantly predicted future hospitalization and health-related quality of life. Gait speed changes were consistent with reported changes in function, supporting responsiveness. The estimated 4-m gait speed minimal important difference was 0.03-0.06 m/s.

Conclusions: The 4-m gait speed is a reliable, valid, and responsive measure of physical function in acute respiratory distress syndrome survivors. The estimated minimal important difference will facilitate sample size calculations for clinical studies evaluating the 4-m gait speed test in acute respiratory distress syndrome survivors.

Citing Articles

Outcome Measures to Evaluate Functional Recovery in Survivors of Respiratory Failure: A Scoping Review.

Parrotte K, Mercado L, Lappen H, Iwashyna T, Hough C, Valley T CHEST Crit Care. 2025; 2(3.

PMID: 39822343 PMC: 11737505. DOI: 10.1016/j.chstcc.2024.100084.

Physical function measures in ICU survivors, where to now? A scoping review.

du Plessis I, Hanekom S, Lupton-Smith A South Afr J Crit Care. 2024; 40(2):e1742.

PMID: 39726835 PMC: 11669153. DOI: 10.7196/SAJCC.2024.v40i2.1742.

A systematic review and meta-analysis of the clinimetric properties of the core outcome measurement instruments for clinical effectiveness trials of nutritional and metabolic interventions in critical illness (CONCISE).

Davies T, Kelly E, van Gassel R, van de Poll M, Gunst J, Casaer M Crit Care. 2023; 27(1):450.

PMID: 37986015 PMC: 10662687. DOI: 10.1186/s13054-023-04729-7.

Construct and criterion validity of muscle ultrasonography for assessment of skeletal muscle in patients recovering from COVID-19.

Mayer K, Kosmac K, Wen Y, Parry S, Dhar S, Foster S Front Physiol. 2023; 14:1231538.

PMID: 37936579 PMC: 10625915. DOI: 10.3389/fphys.2023.1231538.

Functional, imaging, and respiratory evaluation (FIRE) of patients post-hospitalization for COVID-19: protocol for a pilot observational study.

Mayer K, Palakshappa J, Peltan I, Andrew J, Gundel S, Ringwood N Pilot Feasibility Stud. 2022; 8(1):212.

PMID: 36123599 PMC: 9483889. DOI: 10.1186/s40814-022-01151-8.

References

Desai S, Law T, Needham D . Long-term complications of critical care. Crit Care Med. 2010; 39(2):371-9. DOI: 10.1097/CCM.0b013e3181fd66e5. View

Ng S, Ng P, Lee C, Ng E, Tong M, Fong S . Assessing the walking speed of older adults: the influence of walkway length. Am J Phys Med Rehabil. 2013; 92(9):776-80. DOI: 10.1097/PHM.0b013e31828769d0. View

Rice T, Wheeler A, Thompson B, deBoisblanc B, Steingrub J, Rock P . Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011; 306(14):1574-81. PMC: 3770348. DOI: 10.1001/jama.2011.1435. View

Begg M, Parides M . Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med. 2003; 22(16):2591-602. DOI: 10.1002/sim.1524. View

Reuben D, Siu A . An objective measure of physical function of elderly outpatients. The Physical Performance Test. J Am Geriatr Soc. 1990; 38(10):1105-12. DOI: 10.1111/j.1532-5415.1990.tb01373.x. View

Fritz S, Lusardi M . White paper: "walking speed: the sixth vital sign". J Geriatr Phys Ther. 2009; 32(2):46-9. View

Turner D, Schunemann H, Griffith L, Beaton D, Griffiths A, Critch J . The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol. 2009; 63(1):28-36. DOI: 10.1016/j.jclinepi.2009.01.024. View

DePew Z, Karpman C, Novotny P, Benzo R . Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Respir Care. 2013; 58(12):2113-9. PMC: 4005406. DOI: 10.4187/respcare.02471. View

Reuben D, Magasi S, McCreath H, Bohannon R, Wang Y, Bubela D . Motor assessment using the NIH Toolbox. Neurology. 2013; 80(11 Suppl 3):S65-75. PMC: 3662336. DOI: 10.1212/WNL.0b013e3182872e01. View

10.

Palombaro K, Craik R, Mangione K, Tomlinson J . Determining meaningful changes in gait speed after hip fracture. Phys Ther. 2006; 86(6):809-16. View

11.

Cummings S, Studenski S, Ferrucci L . A diagnosis of dismobility--giving mobility clinical visibility: a Mobility Working Group recommendation. JAMA. 2014; 311(20):2061-2. PMC: 5012417. DOI: 10.1001/jama.2014.3033. View

12.

Fan E, Ciesla N, Truong A, Bhoopathi V, Zeger S, Needham D . Inter-rater reliability of manual muscle strength testing in ICU survivors and simulated patients. Intensive Care Med. 2010; 36(6):1038-43. PMC: 2891143. DOI: 10.1007/s00134-010-1796-6. View

13.

Hankinson J, Odencrantz J, Fedan K . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999; 159(1):179-87. DOI: 10.1164/ajrccm.159.1.9712108. View

14.

Barthuly A, Bohannon R, Gorack W . Gait speed is a responsive measure of physical performance for patients undergoing short-term rehabilitation. Gait Posture. 2012; 36(1):61-4. DOI: 10.1016/j.gaitpost.2012.01.002. View

15.

Tilson J, Sullivan K, Cen S, Rose D, Koradia C, Azen S . Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2009; 90(2):196-208. PMC: 2816032. DOI: 10.2522/ptj.20090079. View

16.

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

17.

Leidy N . Psychometric properties of the functional performance inventory in patients with chronic obstructive pulmonary disease. Nurs Res. 1999; 48(1):20-8. DOI: 10.1097/00006199-199901000-00004. View

18.

Enright P, Sherrill D . Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998; 158(5 Pt 1):1384-7. DOI: 10.1164/ajrccm.158.5.9710086. View

19.

Cella D, Eton D, Lai J, Peterman A, Merkel D . Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2003; 24(6):547-61. DOI: 10.1016/s0885-3924(02)00529-8. View

20.

Revicki D, Hays R, Cella D, Sloan J . Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008; 61(2):102-9. DOI: 10.1016/j.jclinepi.2007.03.012. View